XUNFEIHEALTH (02506) Sets 27 March 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal
Bulletin Express
Mar 17
Xunfei Healthcare Technology Co., Ltd. (stock code: 02506) announced that its board of directors will convene on 27 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes consideration of a final dividend recommendation and other routine matters.
The current board comprises one executive director—Dr. Tao Xiaodong—three non-executive directors, and three independent non-executive directors. The announcement, dated 17 March 2026, was issued under the name of Executive Director Dr. Tao Xiaodong.
No additional financial figures or dividend details were disclosed in the notice. The company will publish the audited FY2025 results following the board’s approval.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.